Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Change in Taxes (2016 - 2021)

Historic Change in Taxes for Altimmune (ALT) over the last 6 years, with Q3 2021 value amounting to $2.6 million.

  • Altimmune's Change in Taxes rose 27682.69% to $2.6 million in Q3 2021 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $7.1 million for FY2020, which is 197789.68% up from last year.
  • According to the latest figures from Q3 2021, Altimmune's Change in Taxes is $2.6 million, which was up 27682.69% from -$1.0 million recorded in Q2 2021.
  • Altimmune's 5-year Change in Taxes high stood at $3.4 million for Q1 2020, and its period low was -$2.9 million during Q2 2018.
  • For the 5-year period, Altimmune's Change in Taxes averaged around $357730.5, with its median value being $203008.0 (2017).
  • Its Change in Taxes has fluctuated over the past 5 years, first plummeted by 66291.18% in 2018, then surged by 1098267.35% in 2020.
  • Altimmune's Change in Taxes (Quarter) stood at $1.3 million in 2017, then plummeted by 118.79% to -$237442.0 in 2018, then crashed by 42.98% to -$339501.0 in 2019, then soared by 562.13% to $1.6 million in 2020, then soared by 64.98% to $2.6 million in 2021.
  • Its Change in Taxes stands at $2.6 million for Q3 2021, versus -$1.0 million for Q2 2021 and $135274.0 for Q1 2021.